(Q46118317)

19 December 2017

title

Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study (English)

1 reference

19 December 2017

1 reference

1 reference

Christopher M DeGiorgio

1

1 reference

19 December 2017

Patrick R Miller

2

1 reference

19 December 2017

Ronald Harper

3

1 reference

19 December 2017

Jeffrey Gornbein

4

1 reference

19 December 2017

Lara Schrader

5

1 reference

19 December 2017

Jason Soss

6

1 reference

19 December 2017

Sheba Meymandi

7

1 reference

19 December 2017

language of work or name

English

0 references

publication date

8 September 2014

1 reference

19 December 2017

Journal of Neurology, Neurosurgery and Psychiatry

published in

1 reference

19 December 2017

volume

86

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

65-70

1 reference

19 December 2017

cites work

Drug-resistant epilepsy

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Comparison of seizure control outcomes and the safety of vagus nerve, thalamic deep brain, and responsive neurostimulation: evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

n-3 fatty acids in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

A randomized trial of polyunsaturated fatty acids for refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Consumption of fish products across the lifespan and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

n-3 fatty acids in patients with multiple cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307749

21 January 2018

Identifiers

DOI

10.1136/JNNP-2014-307749

1 reference

19 December 2017

PubMed ID

25201887

1 reference

19 December 2017